News > Glenmark launches country’s first nasal spray for patients
Glenmark launches country’s first nasal spray for patients
![](https://gumlet.assettype.com/nationalherald%2F2022-01%2F9cfb333e-43e8-4e48-a597-d1c1f68d0f95%2F43248488_403.jpg?rect=0%2C0%2C731%2C384&w=1200&auto=format%2Ccompress&ogImage=true)
National Herald | 09/02/2022 03:10 PM | Click to read full article
Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp, on Wednesday announced the launch of nasal spray to treat adult Covid-19 patients.
According to Glenmark, the nitric oxide nasal spray (NONS) will be sold under the brand FabiSpray in India for the treatment of adult patients with Covid-19 who have a high risk of progression of the disease.